Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Takeda’s non-addictive sleeping pill
The new drug is the first prescription insomnia treatment that has not been classified as a controlled substance by the US Drug Enforcement Administration. Rozerem has avoided the
The new drug is the first prescription insomnia treatment that has not been classified as a controlled substance by the US Drug Enforcement Administration. Rozerem has avoided the
The grant will fund a key preclinical efficacy study and support preparations for clinical trials. The company is targeting the start of clinical development in 2006-07. A previous
Swiss drugs giant Novartis AG had displaced Teva as the world’s biggest maker of generic drugs following its purchase of Germany’s Hexal and Hexal’s US unit Eon Labs
Schering-Plough will pay Millennium an upfront payment of $35.5 million and royalties over the US lifespan of Integrilin. In 2006 and 2007, minimum royalty payments for each year
Aderall XR is already approved for the treatment of attention deficit hyperactivity disorder (ADHA) in children aged 6 to 12, and also in adults aged 18 years and
Mars has apparently discovered how to replicate important cocoa compounds known as flavanols, which could present the pharmaceutical industry with a potential new generation of medications. Flavanols are
The pharmaceuticals division posted strong growth in the first half of 2005, with sales up 22% in local currencies (19% in Swiss francs; 25% in U.S. dollars). This
The drug is indicated for use in patients following bowel resection surgery, in order to reduce the risk of postoperative ileus, a condition where the intestine becomes incapable
The study of 98 men with metastatic prostate cancer showed a 20% improvement in median survival for patients who were randomized to receive Provenge compared to placebo. In
In the study, which enrolled 332 patients, those who received the highest dose of NB-001 (0.1%) trended to show healing one day sooner than subjects in the control